about
Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.One size does not fit all: Challenging some dogmas and taboos in drug discovery.Phenotypic Assessment and the Discovery of Topiramate.Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies.iPSC-based drug screening for Huntington's disease.High content analysis in amyotrophic lateral sclerosis.Bringing new dimensions to drug discovery screening: impact of cellular stimulation technologies.Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
P2860
Q31202630-10B11889-C946-4208-A9F3-CEE36847C802Q35874098-ADC700F4-0B67-42DB-BAE1-9EB09B8FAE98Q37101541-4E0F3E0D-983A-4FB5-95FC-4B9A5B55A8A9Q37384418-E7B70FA9-1143-4795-946E-15D7B716EEFEQ38597179-77BDD471-FB94-4473-BBF0-77D37AE1C1CAQ39037865-280E4232-9D72-49EB-A3E0-D88CC85E583FQ39126913-43675C34-B89A-47D4-9E35-AA32CBBB7FA0Q40410650-45966E5A-0503-4B7C-8657-95F0362E9081
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Phenotypic screening in the 21st century.
@en
Phenotypic screening in the 21st century.
@nl
type
label
Phenotypic screening in the 21st century.
@en
Phenotypic screening in the 21st century.
@nl
prefLabel
Phenotypic screening in the 21st century.
@en
Phenotypic screening in the 21st century.
@nl
P2860
P356
P1476
Phenotypic screening in the 21st century.
@en
P2093
Birgit T Priest
Gul Erdemli
P2860
P356
10.3389/FPHAR.2014.00264
P577
2014-12-01T00:00:00Z